Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Magnetic Resonance Imaging for Imaging of Tumor Microenvironment of Metastasis in Patients with Operable Breast Cancer

Trial Status: active

This clinical trial evaluates the use of TMEM-MRI for imaging breast tumors in patients with breast cancer that can be treated by surgery (operable). Tumor microenvironment of metastasis - magnetic resonance imaging (TMEM-MRI) has the ability to detect tumor areas with more leakiness (perfusion), where tumor cells may enter blood vessels to travel to other areas in the body. TMEM-MRI is a test that uses magnets and radio waves to make pictures of organs and structures inside the body. TMEM-MRI may be able to identify tumors with high leakiness that may have a higher chance of coming back after breast cancer treatment, and may also be able help measure a patient's response to earlier treatment.